In summary, the current study demonstrated that downregulation of HMGB2 decreased the infarct size, inflammatory responses, and apoptosis in cerebral injury and had neuroprotective effects against cerebral infarction-induced brain damage. Here, HMGB2 is linked to cerebral infarction.